PREDNISONE- prednisone tablet

Țară: Statele Unite ale Americii

Limbă: engleză

Sursă: NLM (National Library of Medicine)

Ingredient activ:

PREDNISONE (UNII: VB0R961HZT) (PREDNISONE - UNII:VB0R961HZT)

Disponibil de la:

Bryant Ranch Prepack

Calea de administrare:

ORAL

Tip de prescriptie medicala:

PRESCRIPTION DRUG

Indicații terapeutice:

Prednisone tablets, USP are indicated in the following conditions: Endocrine Disorders Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance); congenital adrenal hyperplasia; hypercalcemia associated with cancer; nonsuppurative thyroiditis. Rheumatic Disorders As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose  maintenance therapy), ankylosing spondylitis, acute and subacute bursitis, acute nonspecific tenosynovitis, acute gouty arthritis, post-traumatic osteoarthritis, synovitis of osteoarthritis, epicondylitis. Collagen Diseases During an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythemato

Rezumat produs:

Product: 71335-1294 NDC: 71335-1294-1 14 TABLET in a BOTTLE NDC: 71335-1294-2 10 TABLET in a BOTTLE NDC: 71335-1294-3 18 TABLET in a BOTTLE NDC: 71335-1294-4 20 TABLET in a BOTTLE

Statutul autorizaţiei:

Abbreviated New Drug Application

Caracteristicilor produsului

PREDNISONE- PREDNISONE TABLET
BRYANT RANCH PREPACK
----------
PREDNISONE TABLETS, USP
REVISED: OCTOBER 2015
RX ONLY
DESCRIPTION
Prednisone tablets, USP contain prednisone which is a glucocorticoid.
Glucocorticoids are
adrenocortical steroids, both naturally occurring and synthetic, which
are readily absorbed from the
gastrointestinal tract. The chemical name for prednisone is
pregna-1,4-diene-3,11,20-trione
monohydrate, 17,21-dihydroxy-. The structural formula is represented
below:
C
H O M.W. 358.44
Prednisone is a white to practically white, odorless, crystalline
powder. It is very slightly soluble in
water; slightly soluble in alcohol, chloroform, dioxane, and methanol.
Each tablet, for oral administration, contains 5 mg, 10 mg or 20 mg of
prednisone, USP (anhydrous). In
addition, each tablet contains the following inactive ingredients:
anhydrous lactose, colloidal silicon
dioxide, crospovidone, docusate sodium, magnesium stearate and sodium
benzoate.
Prednisone tablets, USP 20 mg also contain FD&C Yellow No. 6.
CLINICAL PHARMACOLOGY
Naturally occurring glucocorticoids (hydrocortisone and cortisone),
which also have salt-retaining
properties, are used as replacement therapy in adrenocortical
deficiency states. Their synthetic analogs
are primarily used for their potent anti-inflammatory effects in
disorders of many organ systems.
Glucocorticoids cause profound and varied metabolic effects. In
addition, they modify the body’s
immune responses to diverse stimuli.
INDICATIONS AND USAGE
Prednisone tablets, USP are indicated in the following conditions:
ENDOCRINE DISORDERS
21
26
5
Primary or secondary adrenocortical insufficiency (hydrocortisone or
cortisone is the first choice;
synthetic analogs may be used in conjunction with mineralocorticoids
where applicable; in infancy
mineralocorticoid supplementation is of particular importance);
congenital adrenal hyperplasia;
hypercalcemia associated with cancer; nonsuppurative thyroiditis.
RHEUMATIC DISORDERS
As adjunctive therapy for short-term administration (to tide